{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:42:18Z","timestamp":1793662938353,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011068","name":"Fondation Saint-Luc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011068","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02688-7","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T11:14:32Z","timestamp":1742642072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction"],"prefix":"10.1186","volume":"24","clinical-trial-number":[{"clinical-trial-number":"nct03197350","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02599480","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Nassiba","family":"Menghoum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Badii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibille","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vancraeynest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Pasquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Depoix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gruson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Edelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Lhommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masliza","family":"Mahmod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Persu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Piechnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Hellenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignatios","family":"Ikonomidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Krakowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Pieske-Kraigher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-No\u00ebl","family":"Trochu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Van Overstraeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Wachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard L.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Balligand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Beauloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catherine","family":"Pouleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"issue":"2","key":"2688_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","volume":"117","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella GG, Rodolico D, Hill JA. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc Res. 2021;117(2):423\u201334.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"2688_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/ejhf.1902","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer M, Lam CSP, Lund LH, Maurer MS, Borlaug BA. Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease. Eur J Heart Fail. 2020;22(9):1551\u201367.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"2688_CR3","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ejhf.1956","volume":"22","author":"VN Rao","year":"2020","unstructured":"Rao VN, Fudim M, Mentz RJ, Michos ED, Felker GM. Regional adiposity and heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(9):1540\u201350.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2688_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-019-0927-9","volume":"18","author":"M Packer","year":"2019","unstructured":"Packer M. Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue. Cardiovasc Diabetol. 2019;18(1):121.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2688_CR5","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1002\/ejhf.2741","volume":"24","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, van Veldhuisen DJ, Westenbrink BD, de Boer RA, Rienstra M, Gorter TM. Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives. Eur J Heart Fail. 2022;24(12):2238\u201350.","journal-title":"Eur J Heart Fail"},{"key":"2688_CR6","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2022.25","volume":"9","author":"MT Oduah","year":"2023","unstructured":"Oduah MT, Sundaram V, Reddy YN. Epicardial fat in heart failure with preserved ejection fraction: bad actor or just lying around? Card Fail Rev. 2023;9: e06.","journal-title":"Card Fail Rev"},{"issue":"7","key":"2688_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/clc.23644","volume":"44","author":"G van Woerden","year":"2021","unstructured":"van Woerden G, van Veldhuisen DJ, Gorter TM, van Empel VPM, Hemels MEW, Hazebroek EJ, et al. Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction. Clin Cardiol. 2021;44(7):987\u201393.","journal-title":"Clin Cardiol"},{"issue":"3","key":"2688_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009238","volume":"15","author":"G van Woerden","year":"2022","unstructured":"van Woerden G, van Veldhuisen DJ, Manintveld OC, van Empel VPM, Willems TP, de Boer RA, et al. Epicardial adipose tissue and outcome in heart failure with mid-range and preserved ejection fraction. Circ Heart Fail. 2022;15(3): e009238.","journal-title":"Circ Heart Fail"},{"issue":"21","key":"2688_CR9","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jacc.2021.04.003","volume":"77","author":"S Kenchaiah","year":"2021","unstructured":"Kenchaiah S, Ding J, Carr JJ, Allison MA, Budoff MJ, Tracy RP, et al. Pericardial fat and the risk of heart failure. J Am Coll Cardiol. 2021;77(21):2638\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"2688_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.020920","volume":"10","author":"VN Rao","year":"2021","unstructured":"Rao VN, Bush CG, Mongraw-Chaffin M, Hall ME, Clark D 3rd, Fudim M, et al. Regional adiposity and risk of heart failure and mortality: the jackson heart study. J Am Heart Assoc. 2021;10(14): e020920.","journal-title":"J Am Heart Assoc"},{"key":"2688_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijcard.2022.04.009","volume":"357","author":"AA Mahabadi","year":"2022","unstructured":"Mahabadi AA, Anapliotis V, Dykun I, Hendricks S, Al-Rashid F, L\u00fcdike P, et al. Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease. Int J Cardiol. 2022;357:140\u20135.","journal-title":"Int J Cardiol"},{"issue":"8","key":"2688_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jchf.2020.06.003","volume":"8","author":"TM Gorter","year":"2020","unstructured":"Gorter TM, van Woerden G, Rienstra M, Dickinson MG, Hummel YM, Voors AA, et al. Epicardial adipose tissue and invasive hemodynamics in heart failure with preserved ejection fraction. JACC Heart Fail. 2020;8(8):667\u201376.","journal-title":"JACC Heart Fail"},{"issue":"3","key":"2688_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure: endorsed by the Canadian heart failure society, heart failure association of India, cardiac society of Australia and New Zealand, and chinese heart failure association. Eur J Heart Fail. 2021;23(3):352\u201380.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"2688_CR14","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/jcm9041110","volume":"9","author":"A Bayes-Genis","year":"2020","unstructured":"Bayes-Genis A, Bisbal F, Nunez J, Santas E, Lupon J, Rossignol P, et al. Transitioning from preclinical to clinical heart failure with preserved ejection fraction: a mechanistic approach. J Clin Med. 2020;9(4):1110.","journal-title":"J Clin Med"},{"key":"2688_CR15","doi-asserted-by":"crossref","unstructured":"Pouleur AC, Menghoum N, Cumps J, Marino A, Badii M, Lejeune S, et al. Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project. EBioMedicine. 2024; 107: 105264.","DOI":"10.1016\/j.ebiom.2024.105264"},{"issue":"2","key":"2688_CR16","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/ehf2.13187","volume":"8","author":"Y Sun","year":"2021","unstructured":"Sun Y, Wang N, Li X, Zhang Y, Yang J, Tse G, et al. Predictive value of H(2) FPEF score in patients with heart failure with preserved ejection fraction. ESC Heart Fail. 2021;8(2):1244\u201352.","journal-title":"ESC Heart Fail"},{"key":"2688_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101941","volume":"29","author":"SP Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo SP, Juvanhol LL, Bressan J, Hermsdorff HHM. Triglyceride glucose index: a new biomarker in predicting cardiovascular risk. Prev Med Rep. 2022;29: 101941.","journal-title":"Prev Med Rep"},{"issue":"11","key":"2688_CR18","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/jamacardio.2023.3003","volume":"8","author":"JL Balligand","year":"2023","unstructured":"Balligand JL, Brito D, Brosteanu O, Casadei B, Depoix C, Edelmann F, et al. Repurposing the beta3-adrenergic receptor agonist mirabegron in patients with structural cardiac disease: the beta3-LVH Phase 2b randomized clinical trial. JAMA Cardiol. 2023;8(11):1031\u201340.","journal-title":"JAMA Cardiol"},{"issue":"5","key":"2688_CR19","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ehf2.12306","volume":"5","author":"AC Pouleur","year":"2018","unstructured":"Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, et al. Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail. 2018;5(5):830\u201341.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"2688_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12968-018-0477-4","volume":"20","author":"C Roy","year":"2018","unstructured":"Roy C, Slimani A, de Meester C, Amzulescu M, Pasquet A, Vancraeynest D, et al. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction. J Cardiovasc Magn Reson. 2018;20(1):55.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"18","key":"2688_CR21","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","volume":"118","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Jensen MD, Kitzman DW, Lam CSP, Obokata M, Rider OJ. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardiovasc Res. 2023;118(18):3434\u201350.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"2688_CR22","doi-asserted-by":"publisher","first-page":"724","DOI":"10.4239\/wjd.v14.i6.724","volume":"14","author":"YJ Shi","year":"2023","unstructured":"Shi YJ, Dong GJ, Guo M. Targeting epicardial adipose tissue: a potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus. World J Diabetes. 2023;14(6):724\u201340.","journal-title":"World J Diabetes"},{"issue":"9","key":"2688_CR23","volume":"15","author":"S Zain","year":"2023","unstructured":"Zain S, Shamshad T, Kabir A, Khan AA. Epicardial adipose tissue and development of atrial fibrillation (AFIB) and heart failure with preserved ejection fraction (HFpEF). Cureus. 2023;15(9): e46153.","journal-title":"Cureus"},{"key":"2688_CR24","doi-asserted-by":"publisher","first-page":"117954682110292","DOI":"10.1177\/11795468211029244","volume":"15","author":"JA Sousa","year":"2021","unstructured":"Sousa JA, Mendon\u00e7a MI, Serr\u00e3o M, Borges S, Henriques E, Freitas S, et al. Epicardial adipose tissue: the genetics behind an emerging cardiovascular risk marker. Clin Med Insights Cardiol. 2021;15:11795468211029244.","journal-title":"Clin Med Insights Cardiol"},{"key":"2688_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2021.666260","volume":"2","author":"G Iacobellis","year":"2021","unstructured":"Iacobellis G. aging effects on epicardial adipose tissue. Front Aging. 2021;2: 666260.","journal-title":"Front Aging"},{"issue":"1","key":"2688_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12933-019-0807-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Liu B, Li Y, Jing X, Deng S, Yan Y, et al. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2019;18(1):3.","journal-title":"Cardiovasc Diabetol"},{"issue":"20","key":"2688_CR27","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","volume":"71","author":"M Packer","year":"2018","unstructured":"Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 2018;71(20):2360\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"2688_CR28","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1161\/CIRCULATIONAHA.111.039586","volume":"126","author":"S Greulich","year":"2012","unstructured":"Greulich S, Maxhera B, Vandenplas G, de Wiza DH, Smiris K, Mueller H, et al. Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction. Circulation. 2012;126(19):2324\u201334.","journal-title":"Circulation"},{"issue":"22","key":"2688_CR29","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1042\/CS20190578","volume":"133","author":"SR Anthony","year":"2019","unstructured":"Anthony SR, Guarnieri AR, Gozdiff A, Helsley RN, Phillip Owens A, Tranter M. Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis. Clin Sci. 2019;133(22):2329\u201344.","journal-title":"Clin Sci"},{"issue":"2","key":"2688_CR30","first-page":"83","volume":"3","author":"M Pezeshkian","year":"2013","unstructured":"Pezeshkian M, Mahtabipour MR. Epicardial and subcutaneous adipose tissue Fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft. Bioimpacts. 2013;3(2):83\u20139.","journal-title":"Bioimpacts"},{"issue":"9","key":"2688_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2023.100657","volume":"2","author":"SA Goldman","year":"2023","unstructured":"Goldman SA, Requena-Ibanez JA, Devesa A, Santos-Gallego CG, Badimon JJ, Fuster V. Uncovering the role of epicardial adipose tissue in heart failure with preserved ejection fraction. JACC Adv. 2023;2(9): 100657.","journal-title":"JACC Adv"},{"issue":"1","key":"2688_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbrc.2013.01.078","volume":"432","author":"H Imoto-Tsubakimoto","year":"2013","unstructured":"Imoto-Tsubakimoto H, Takahashi T, Ueyama T, Ogata T, Adachi A, Nakanishi N, et al. Serglycin is a novel adipocytokine highly expressed in epicardial adipose tissue. Biochem Biophys Res Commun. 2013;432(1):105\u201310.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2688_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/cvr\/cvv208","volume":"108","author":"B Gaborit","year":"2015","unstructured":"Gaborit B, Venteclef N, Ancel P, Pelloux V, Gariboldi V, Leprince P, et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res. 2015;108(1):62\u201373.","journal-title":"Cardiovasc Res"},{"issue":"7 Suppl","key":"2688_CR34","doi-asserted-by":"publisher","first-page":"3b","DOI":"10.1016\/j.amjcard.2015.01.034","volume":"115","author":"DA Pascual-Figal","year":"2015","unstructured":"Pascual-Figal DA, Januzzi JL. The biology of ST2: the international ST2 consensus panel. Am J Cardiol. 2015;115(7 Suppl):3b\u20137b.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2688_CR35","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1038\/s41598-019-46676-w","volume":"9","author":"E Vianello","year":"2019","unstructured":"Vianello E, Dozio E, Bandera F, Schmitz G, Nebuloni M, Longhi E, et al. Dysfunctional EAT thickness may promote maladaptive heart remodeling in CVD patients through the ST2-IL33 system, directly related to EPAC protein expression. Sci Rep. 2019;9(1):10331.","journal-title":"Sci Rep"},{"issue":"6","key":"2688_CR36","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jcmg.2020.10.017","volume":"14","author":"T Mason","year":"2021","unstructured":"Mason T, Coelho-Filho OR, Verma S, Chowdhury B, Zuo F, Quan A, et al. Empagliflozin reduces myocardial extracellular volume in patients with type 2 diabetes and coronary artery disease. JACC Cardiovasc Imaging. 2021;14(6):1164\u201373.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"2688_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","volume":"17","author":"T Sato","year":"2018","unstructured":"Sato T, Aizawa Y, Yuasa S, Kishi S, Fuse K, Fujita S, et al. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018;17(1):6.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2688_CR38","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3390\/cells10082150","volume":"10","author":"W Masson","year":"2021","unstructured":"Masson W, Lavalle-Cobo A, Nogueira JP. Effect of SGLT2-Inhibitors on epicardial adipose tissue: a meta-analysis. Cells. 2021;10(8):2150.","journal-title":"Cells"},{"issue":"15","key":"2688_CR39","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","volume":"141","author":"TA Zelniker","year":"2020","unstructured":"Zelniker TA, Bonaca MP, Furtado RHM, Mosenzon O, Kuder JF, Murphy SA, et al. Effect of Dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial. Circulation. 2020;141(15):1227\u201334.","journal-title":"Circulation"},{"issue":"3","key":"2688_CR40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40618-021-01687-1","volume":"45","author":"G Iacobellis","year":"2022","unstructured":"Iacobellis G, Baroni MG. Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat. J Endocrinol Invest. 2022;45(3):489\u201395.","journal-title":"J Endocrinol Invest"},{"issue":"16","key":"2688_CR41","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451\u201361.","journal-title":"N Engl J Med"},{"issue":"12","key":"2688_CR42","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089\u201398.","journal-title":"N Engl J Med"},{"issue":"9","key":"2688_CR43","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","volume":"29","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA, Kitzman DW, Davies MJ, Rasmussen S, Barros E, Butler J, et al. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nat Med. 2023;29(9):2358\u201365.","journal-title":"Nat Med"},{"issue":"11","key":"2688_CR44","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ejhf.2337","volume":"23","author":"NR Pugliese","year":"2021","unstructured":"Pugliese NR, Paneni F, Mazzola M, De Biase N, Del Punta L, Gargani L, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure. Eur J Heart Fail. 2021;23(11):1858\u201371.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"2688_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2023.101979","volume":"48","author":"A Wu","year":"2023","unstructured":"Wu A, Yang Z, Zhang X, Lin Z, Lu H. Association between epicardial adipose tissue and left atrial and ventricular function in patients with heart failure: a systematic review and meta-analysis. Curr Probl Cardiol. 2023;48(12): 101979.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"2688_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12933-023-01778-8","volume":"22","author":"J Liu","year":"2023","unstructured":"Liu J, Yu Q, Li Z, Zhou Y, Liu Z, You L, et al. Epicardial adipose tissue density is a better predictor of cardiometabolic risk in HFpEF patients: a prospective cohort study. Cardiovasc Diabetol. 2023;22(1):45.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2688_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/00015385.2020.1770460","volume":"76","author":"S Lejeune","year":"2021","unstructured":"Lejeune S, Roy C, Slimani A, Pasquet A, Vancraeynest D, Beauloye C, et al. Heart failure with preserved ejection fraction in Belgium: characteristics and outcome of a real-life cohort. Acta Cardiol. 2021;76(7):697\u2013706.","journal-title":"Acta Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02688-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02688-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T22:03:38Z","timestamp":1742940218000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02688-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2688"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02688-7","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the Cliniques universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain, and all participants gave written consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}